Back

RE: A synthetic peptide from transforming growth factor-β1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats. Cardiovascular Research, Volume 81, Issue 3, 15 February 2009, Pages 601–609. Javier Díez, https://doi.org/10.1093/cvr/cvn315

Cardiovascular Research

5 August 2020
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Genetic regulation of myocardial fibrosis in hypertrophic cardiomyopathy
27 August 2021
thumbnail
Congress Presentation
RKER-012, a novel modified ActRIIB ligand trap, attenuated right ventricular cardiomyopathy in a preclinical model of pulmonary arterial hypertension.
31 August 2024
thumbnail
Congress Presentation
Role of platelet GARP in TGFB activation
27 August 2021
thumbnail
Congress Presentation
Pirfenidone added to standard therapy for myocardial infarction further reduces left ventricular fibrosis: a preclinical study
21 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources